Cargando…
Casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155463/ https://www.ncbi.nlm.nih.gov/pubmed/37146726 http://dx.doi.org/10.1016/j.jinf.2023.04.019 |
| _version_ | 1785036333931036672 |
|---|---|
| author | Gao, Ming Ao, Guangyu Hao, Xiaodan Xie, Bo |
| author_facet | Gao, Ming Ao, Guangyu Hao, Xiaodan Xie, Bo |
| author_sort | Gao, Ming |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10155463 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101554632023-05-03 Casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis Gao, Ming Ao, Guangyu Hao, Xiaodan Xie, Bo J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2023-07 2023-05-03 /pmc/articles/PMC10155463/ /pubmed/37146726 http://dx.doi.org/10.1016/j.jinf.2023.04.019 Text en © 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Gao, Ming Ao, Guangyu Hao, Xiaodan Xie, Bo Casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis |
| title | Casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis |
| title_full | Casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis |
| title_fullStr | Casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis |
| title_full_unstemmed | Casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis |
| title_short | Casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis |
| title_sort | casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with covid-19: a systematic review with meta-analysis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155463/ https://www.ncbi.nlm.nih.gov/pubmed/37146726 http://dx.doi.org/10.1016/j.jinf.2023.04.019 |
| work_keys_str_mv | AT gaoming casirivimabimdevimabtreatmentisassociatedwithreducedratesofmortalityandhospitalizationinpatientswithcovid19asystematicreviewwithmetaanalysis AT aoguangyu casirivimabimdevimabtreatmentisassociatedwithreducedratesofmortalityandhospitalizationinpatientswithcovid19asystematicreviewwithmetaanalysis AT haoxiaodan casirivimabimdevimabtreatmentisassociatedwithreducedratesofmortalityandhospitalizationinpatientswithcovid19asystematicreviewwithmetaanalysis AT xiebo casirivimabimdevimabtreatmentisassociatedwithreducedratesofmortalityandhospitalizationinpatientswithcovid19asystematicreviewwithmetaanalysis |